Soluble human leukocyte antigen-G serum levels in patients with acquired immune deficiency syndrome affected by different disease-defining conditions before and after antiretroviral treatment

Human Immunology

Volumn 72, Issue 9, 2011, Pages 712-716

  Murdaca, Giuseppe ^a   Contini, Paola ^a   Setti, Maurizio ^a   Cagnati, Paola ^a   Spanò, Francesca ^a   Lantieri, Francesca ^b   Puppo, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

AIDS; HAART; Kaposi's sarcoma; Opportunistic infections; Soluble HLA G molecules

Indexed keywords

HLA G ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; KAPOSI SARCOMA; LYMPHOCYTE MEMBRANE; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PHENOTYPE; PRIORITY JOURNAL; TREATMENT RESPONSE; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOLOGICAL MARKERS; BIOMARKERS, PHARMACOLOGICAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HIV; HLA-G ANTIGENS; HUMANS; RNA, VIRAL; SARCOMA, KAPOSI; VIRUS REPLICATION; WASTING SYNDROME;

EID: 84860390732     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.008     Document Type: Article

References (41)

1. Ploegh H.L., Orr H.T., Strominger J.L. Major histocompatibility antigens: The human (HLA-A, -B, -C) and murine (H-2K, H-2D) class. Mol Cells 1981, 24:287-299.
2. O'Callaghan C.A., Bell J.L. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 1998, 163:129-138.
3. Pellegrino M.A., Russo C., Allison J.P. HLA antigens in serum. Methods Enzymol 1984, 108:614-624.
4. Krangel M.S. Secretion of HLA-A and-B antigens via an alternative RNA splicing pathway. J Exp Med 1986, 163:1173-1190.
5. Krangel M.S. Two forms of HLA class I molecules in human plasma. Hum Immunol 1987, 20:155-165.
6. Dobbe L.M., Stam N.J., Neefjes J.J., Giphart M. Biochemical complexity of serum HLA class I molecules. Immunogenetics 1988, 27:203-210.
7. Tabayoyong W.B., Zavazava N. Soluble HLA revisited. Leuk Res 2007, 31:121-125.
8. Favier B., LeMaoult J., Rouas-Freiss N., Moreau P., Menier P., Carosella E.D., et al. Research on HLA-G: An update. Tissue Antigens 2007, 69:207-211.
9. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008, 111:4862-4870.
10. Rebmann V., Busemann A., Lindemann M., Grosse-Wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 2003, 64:1017-1024.
11. Pistoia V., Morandi F., Wang X., Ferrone S. Soluble HLA-G: Are they clinically relevant?. Semin Cancer Biol 2007, 17:469-479.
12. Fainardi E., Rizzo R., Melchiorri L., Stignani M., Castellazzi M., Tamborino C., et al. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis. Mult Scler 2008, 14:446-454.
13. Campoli M., Ferrone S. Tumour escape mechanisms: Potential role of soluble HLA antigens and NK cells activating ligands. Tissue Antigens 2008, 72:321-334.
14. Chen H.X., Chen B.G., Shi W.W., Zhen R., Xu D.P., Lin A., et al. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Hum Immunol 2011, 71:159-165.
15. Souto F.J., Crispim J.C., Ferreira S.C., da Silva A.S., Bassi C.L., Soares C.P., et al. expression is associated with multiple clinical and histopathologic forms of chronic hepatitis B virus infection. J Viral Hepat 2011, 18:102-105.
16. Weng P.J., Fu Y.M., Ding S.X., Xu D.P., Lin A., Yan W.H., et al. Elevation of plasma soluble HLA-G in patients with chronic hepatitis C virus (HCV) infection. Hum Immunol 2011, 72:406-411.
17. Yan W.H., Lin A., Chen B.G., Chen S.Y. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 2009, 200:820-826.
18. Lozano J.M., Gonzalez R., Kindelan J.M., Rouas-Freiss N., Caballos R., Dausset J., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002, 16:347-351.
19. Donaghy L., Gros F., Amiot F., Mary C., Maillard A., Guiguen C., et al. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin Exp Immunol 2007, 147:236-240.
20. Lajoie J., Massinga Loembe M., Poudrier J., Guédou F., Pépin J., Labbé A.C., et al. Blood soluble HLA-G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers. Hum Immunol 2010, 71:182-185.
21. Puppo F., Brenci S., Lanza L., Bosco O., Imro M.A., Scudeletti M., et al. Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum Immunol 1994, 40:259-266.
22. Murdaca G., Contini P., Setti M., Cagnati P., Villa R., Lantieri F., et al. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: Correlation with clinical outcome. Hum Immunol 2007, 68:894-900.
23. Murdaca G., Contini P., Setti M., Cagnati P., Lantieri F., Indiveri F., et al. Behavior of non classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: Comparison with classical soluble. HLA-A, -B, -C antigens and potential role in immune reconstitution. Clin Immunol 2009, 133:238-244.
24. Rouas-Freiss N., Marchal R.E., Kirszenbaum M., Dausset J., Carosella E.D. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?. Proc Natl Acad Sci U S A 1997, 94:5249-5254.
25. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., et al. Soluble. HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003, 33:125-134.
26. Contini P., Ghio M., Merlo M., Poggi A., Indiveri F., Puppo F., et al. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA Class I molecules is Fas ligand/Fas mediated: Evidence for the involvement of p56lck, calcium calmodulin kinase II, and calcium-independent protein kinase C signaling pathways and for NF-κB and NF-AT nuclear translocation. J Immunol 2005, 175:7244-7254.
27. Bainbridge D.R., Ellis S.A., Sargent I.L. HLA G suppresses proliferation of CD4 T-lymphocytes. J Reprod Immunol 2000, 48:17-26.
28. LeMaoult J., Krawice-Radanne I., Dausset J., Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD41 T cells. Proc Natl Acad Sci U S A 2004, 101:7064-7069.
29. Naji A., Le Rond S., Durrbach A., Krawice-Radanne I., Creput C., Daouya M., et al. CD3+CD4low and CD3+CD8low are induced by HLA-G: Novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 2007, 110:3936-3948.
30. Le Maoult J., Zafaranloo K., Le Danff C., Carosella E.D. HLA G up-regulates ILT2, 242 ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NKcells, and T cells. FASEB J 2005, 19:662-664.
31. Menier C., Rouas-Freiss N., Favier B., Le Maoult J., Moreau P., Carosella E.D. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule C. Tissue Antigens 2009, 75:201-206.
32. Lajoie J., Fontaine J., Tremblay C., Routy J.P., Poudrier J., Roger M., et al. Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS 2009, 23:1437-1440.
33. Lozano J.M., González R., Luque J., Frias M., Rivero A., Peña J., et al. CD8+HLA-G+ Regulatory T cells are expanded in HIV-1 infected patients. Viral Immunol 2009, 22:463-465.
34. Huang J., Burke P., Yang Y., Seiss K., Beamon J., Cung T., et al. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interactions with ILT4. J Virol 2010, 84:10784-10791.
35. Cabello A., Rivero A., Garcia M.J., Lozano J.M., Torre-Cisneros J., González R., et al. HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Hum Immunol 2003, 64:1045-1049.
36. Rivero A., Lozano J.M., González R., García-Jurado G., Camacho A., Torres-Cisneros J., et al. Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients. Hum Immunol 2007, 68:303-306.
37. Maio M., Gulwani G., Langer J.A., Kerbel R.S., Duigou G.J., Fisher P.B., et al. Modulation by interferons of hla antigen, high-molecular weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Cancer Res 1989, 49:2980-2987.
38. Aulitzky W.E., Grosse-Wilde H., Westhoff U., Tilg H., Aulitzky W., Gastl G., et al. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin Exp Immunol 1991, 86:236-239.
39. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J., et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999, 11:803-811.
40. Fan J., Bass H.Z., Fahey J.L. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993, 151:5031-5040.
41. Brockman M.A., Kwon D.S., Tighe D.P., Pavlik D.F., Rosato P.C., Sela J., et al. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009, 114:346-356.